Top

Published in:

Open Access 01-12-2015 | Research

Cost-effectiveness of a cardiac output-guided haemodynamic therapy algorithm in high-risk patients undergoing major gastrointestinal surgery

Authors: Zia Sadique, David A. Harrison, Richard Grieve, Kathryn M. Rowan, Rupert M. Pearse, for the OPTIMISE study group

Published in: Perioperative Medicine | Issue 1/2015

Abstract

Background

The use of cardiac output monitoring to guide intra-venous fluid and inotropic therapies may improve peri-operative outcomes, but uncertainty exists regarding clinical effectiveness and robust cost-effectiveness evidence is lacking. The objective of the study was to evaluate the cost-effectiveness of peri-operative cardiac output-guided haemodynamic therapy versus usual care in high-risk patients undergoing major gastrointestinal surgery.

Methods

The study undertook a cost-effectiveness analysis using data from a multi-centre randomised trial that recruited patients from 17 hospitals in the United Kingdom. The trial compared cardiac output-guided, haemodynamic therapy algorithm for intra-venous fluid and inotrope (dopexamine) infusion during and 6 h following surgery, with usual care. Resource use and outcome data on 734 high-risk trial patients aged over 50 years undergoing major gastrointestinal surgery were used to report cost-effectiveness at 6 months and to project lifetime cost-effectiveness. The cost-effectiveness analysis used information on health-related quality of life (QoL) at randomisation, 30 days, and 6 months combined with information on vital status to report quality-adjusted life years (QALYs). Each QALY was valued using the National Institute for Health and Care Excellence (NICE) recommended threshold of willingness to pay (£20,000 per QALY) in conjunction with the costs of each group to report the incremental net monetary benefits (INB) of the treatment algorithm versus usual care.

Results

The mean [SD] quality of life at 30 days and 6 months was similar between the treatment groups (at 6 months, intervention group 0.73 [0.28] versus usual care group 0.71 [0.30]; mean gain 0.03 [95 % confidence interval (CI) −0.01 to 0.08]). At 6 months, survival, mean QALYs and mean healthcare costs (intervention group £8574 versus usual care group £8974) were also similar. At the cost-effectiveness threshold of £20,000 per QALY gained, the incremental net benefit of haemodynamic therapy over the patients’ lifetime was positive (£4168 [95 % CI −£3063 to £11,398]). This corresponds to an 87 % probability that this intervention is cost-effective.

Conclusions

Cardiac output-guided haemodynamic therapy algorithm was associated with an average cost reduction and improvement in QALY and is likely to be cost-effective. Further research is needed to confirm the clinical and cost-effectiveness of this treatment.

Trial registration

ISRCTN04386758

Available only for authorised users

Agency for Healthcare Research and Quality. Esophageal Doppler ultrasound-based cardiac output monitoring for real-time therapeutic management of hospitalized patients. 2007. http://www.cms.gov/Medicare/Coverage/DeterminationProcess/downloads/id45TA.pdf.

Bartha E, Davidson T, Hommel A, Thorngren KG, Carlsson P, Kalman S. Cost-effectiveness analysis of goal-directed hemodynamic treatment of elderly hip fracture patients: before clinical research starts. Anesthesiology. 2012;117(3):519–30.CrossRefPubMed

Bartha E, Davidson T, Brodtkorb TH, Carlsson P, Kalman S. Value of information: interim analysis of a randomized, controlled trial of goal-directed hemodynamic treatment for aged patients. Trials. 2013;14:205.PubMedCentralCrossRefPubMed

Boltz MM, Hollenbeak CS, Julian KG, Ortenzi G, Dillon PW. Hospital costs associated with surgical site infections in general and vascular surgery patients. Surgery. 2011;150(5):934–42. doi:10.1016/j.surg.2011.04.006.CrossRefPubMed

Briggs A, Sculpher M, Claxton K. Decision modelling for health economic evaluation. Oxford: Oxford University Press; 2006.

Claxton K. The irrelevance of inference: a decision-making approach to the stochastic evaluation of health care technologies. J Health Econ. 1999;18(3):341–64.CrossRefPubMed

Claxton K, Posnett J. An economic approach to clinical trial design and research priority-setting. Health Econ. 1996;5(6):513–24.CrossRefPubMed

Department of Health. NHS reference costs 2012–2013. London: Department of Health; 2013.

Dolan P, Gudex C, Kind P, Williams A. A social tariff for EuroQoL: results from a UK general population survey. CHE Discussion Paper 138. York: Centre for Health Economics, University of York; 1999.

Ebm C, Cecconi M, Sutton L, Rhodes A. A cost-effectiveness analysis of postoperative goal-directed therapy for high-risk surgical patients. Crit Care Med. 2014;42(5):1194–203. doi:10.1097/CCM.0000000000000164.CrossRefPubMed

Fenwick E, Wilson J, Sculpher M, Claxton K. Pre-operative optimisation employing dopexamine or adrenaline for patients undergoing major elective surgery: a cost-effectiveness analysis. Intensive Care Med. 2002;28(5):599.CrossRefPubMed

Fenwick E, O'Brien BJ, Briggs A. Cost-effectiveness acceptability curves—facts, fallacies and frequently asked questions. Health Econ. 2004;13(5):405–15.CrossRefPubMed

Grocott MP, Dushianthan A, Hamilton MA, Mythen MG, Harrison D, Rowan K, et al. Perioperative increase in global blood flow to explicit defined goals and outcomes following surgery. The Cochrane database of systematic reviews. 2012;11, CD004082. doi:10.1002/14651858.CD004082.pub5.PubMed

Guest JF, Boyd O, Hart WM, Grounds RM, Bennett ED. A cost analysis of a treatment policy of a deliberate perioperative increase in oxygen delivery in high risk surgical patients. Intensive Care Med. 1997;23(1):85–90.CrossRefPubMed

Huang DT, Clermont G, Dremsizov TT, Angus DC, Pro CI. Implementation of early goal-directed therapy for severe sepsis and septic shock: a decision analysis. Crit Care Med. 2007;35(9):2090–100.CrossRefPubMed

Joint Formulary Committee. British National Formulary (online) London: BMJ Group and Pharmaceutical Press; (Accessed on 25th October 2013).

Jones AE, Troyer JL, Kline JA. Cost-effectiveness of an emergency department-based early sepsis resuscitation protocol. Crit Care Med. 2011;39(6):1306–12. doi:10.1097/CCM.0b013e31821201be.PubMedCentralCrossRefPubMed

Khuri SF, Henderson WG, DePalma RG, Mosca C, Healey NA, Kumbhani DJ, et al. Determinants of long-term survival after major surgery and the adverse effect of postoperative complications. Ann Surg. 2005;242(3):326–41. discussion 41–3.PubMedCentralPubMed

Latimer N. Survival analysis for economic evaluations alongside clinical trials—extrapolation with patient-level data. NICE DSU technical support documents: No. 14. Sheffield: University of Sheffield; 2011.

Latimer NR. Survival analysis for economic evaluations alongside clinical trials—extrapolation with patient-level data: inconsistencies, limitations, and a practical guide. Med Decis Making. 2013;33(6):743–54.CrossRefPubMed

Manca A, Hawkins N, Sculpher MJ. Estimating mean QALYs in trial-based cost-effectiveness analysis: the importance of controlling for baseline utility. Health Econ. 2005;14(5):487–96.CrossRefPubMed

National Institute for Health and Care Excellence. Guide to the methods of technology appraisal. London: National Institute for Health and Care Excellence; 2013.

National Institute for Health and Care Excellence. CardioQ-ODM oesophageal Doppler monitor. NICE medical technology guidance [MTG3]. 2011. https://www.nice.org.uk/guidance/mtg3.

NHS Blood & Transplant. National blood and blood products price list 2013/2014. http://www.nhsbt.nhs.uk/.

Office of National Statistics. Interim Life Tables, 2008–2010. In: Newport: Office of National Statistics. 2011. http://www.ons.gov.uk/ons/rel/lifetables/interim-life-tables/2008-2010/index.html.

Pearse RM, Ackland GL. Perioperative fluid therapy. BMJ. 2012;344, e2865. doi:10.1136/bmj.e2865.CrossRefPubMed

Peake SL, Delaney A, Bailey M, Bellomo R, et al. Goal-directed resuscitation for patients with early septic shock. N Engl J Med. 2014;371(16):1496–506. doi:10.1056/NEJMoa1404380.

Pearse RM, Holt PJ, Grocott MP. Managing perioperative risk in patients undergoing elective non-cardiac surgery. BMJ. 2011;343:d5759. doi:10.1136/bmj.d5759.CrossRefPubMed

Pearse RM, Moreno RP, Bauer P, Pelosi P, Metnitz P, Spies C, et al. Mortality after surgery in Europe: a 7 day cohort study. Lancet. 2012;380(9847):1059–65. doi:10.1016/S0140-6736(12)61148-9.

Pearse RM, Harrison DA, MacDonald N, Gillies MA, Blunt M, Ackland G, et al. Effect of a perioperative, cardiac output-guided hemodynamic therapy algorithm on outcomes following major gastrointestinal surgery: a randomized clinical trial and systematic review. JAMA. 2014;311(21):2181–90. doi:10.1001/jama.2014.5305.CrossRefPubMed

Rubin DB. Multiple imputation for nonresponse in surveys. New York: J Wiley & Sons; 1987.CrossRef

Talmor D, Greenberg D, Howell MD, Lisbon A, Novack V, Shapiro N. The costs and cost-effectiveness of an integrated sepsis treatment protocol. Crit Care Med. 2008;36(4):1168–74. doi:10.1097/CCM.0b013e318168f649.CrossRefPubMed

Weiser TG, Regenbogen SE, Thompson KD, Haynes AB, Lipsitz SR, Berry WR, et al. An estimation of the global volume of surgery: a modelling strategy based on available data. Lancet. 2008;372(9633):139–44. doi:10.1016/S0140-6736(08)60878-8.CrossRefPubMed

Yealy DM, Kellum JA, Huang DT, Barnato AE, Weissfeld LA, et al. A randomized trial of protocol-based care for early septic shock. N Engl J Med. 2014;370(18):1683–93. doi:10.1056/NEJMoa1401602.

Title: Cost-effectiveness of a cardiac output-guided haemodynamic therapy algorithm in high-risk patients undergoing major gastrointestinal surgery
Authors: Zia Sadique
David A. Harrison
Richard Grieve
Kathryn M. Rowan
Rupert M. Pearse
for the OPTIMISE study group
Publication date: 01-12-2015
Publisher: BioMed Central
Published in: Perioperative Medicine / Issue 1/2015
Electronic ISSN: 2047-0525
DOI: https://doi.org/10.1186/s13741-015-0024-x

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Cost-effectiveness of a cardiac output-guided haemodynamic therapy algorithm in high-risk patients undergoing major gastrointestinal surgery

Abstract

Background

Methods

Results

Conclusions

Trial registration

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Trial registration

Please log in to get access to this content

Other articles of this Issue 1/2015

Effects of different colloid infusions on ROTEM and Multiplate during elective brain tumour neurosurgery

Validity of the Postoperative Morbidity Survey after abdominal aortic aneurysm repair—a prospective observational study

Potential return on investment for implementation of perioperative goal-directed fluid therapy in major surgery: a nationwide database study

Variation in haemodynamic monitoring for major surgery in European nations: secondary analysis of the EuSOS dataset

Goal-directed therapy: what we know and what we need to know

Perioperative fluid therapy: a statement from the international Fluid Optimization Group